Skip to content

Canceled by the investigator. A prospective clinical study of oral metformin in the treatment of secondary lymphedema

A prospective clinical study of oral metformin in the treatment of secondary lymphedema

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063873
Enrollment
Unknown
Registered
2022-09-19
Start date
2022-09-19
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphedema

Interventions

one:Take metformin orally

Sponsors

Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with clinically confirmed secondary lymphedema of unilateral or bilateral limbs (International Society of Lymphedema classification stage I-II) with a history of more than 3 months; 2. Age range: 18 to 80 years old;

Exclusion criteria

Exclusion criteria: 1. Patients with systemic diseases, infection or bleeding tendency; 2. Patients with medical contraindications to metformin use were excluded, including a history of allergies, gastrointestinal intolerance, or other serious systemic conditions (e.g., renal failure, liver dysfunction, congestive heart failure, neurological or psychological disorders); 3. Patients who are breastfeeding or preparing for pregnancy; 4. Minors (<18 years old) or patients over 80 years old; 5. Suffer from mental illness that may affect participation in the project; 6. Diagnosis of immune deficiency; 7. Patients who are not suitable to participate in this experiment according to the evaluation of the investigator;

Design outcomes

Primary

MeasureTime frame
Limb circumference;

Secondary

MeasureTime frame
Lymphoscintigraphy;Venous blood;

Countries

China

Contacts

Public ContactDeng Chengliang
cheliadeng@sina.com15085115296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026